<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Disruption of the integrity of the blood-brain barrier (<z:chebi fb="2" ids="33602">BBB</z:chebi>) is an important mechanism of cerebrovascular diseases, including neonatal cerebral <z:mp ids='MP_0005039'>hypoxia</z:mp>-<z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> (HI) </plain></SENT>
<SENT sid="1" pm="."><plain>Although both tissue-type plasminogen activator (tPA) and matrix metalloproteinase-9 (MMP-9) can produce <z:chebi fb="2" ids="33602">BBB</z:chebi> damage, their relationship in neonatal cerebral HI is unclear </plain></SENT>
<SENT sid="2" pm="."><plain>Here we use a <z:e sem="disease" ids="C1519106" disease_type="Experimental Model of Disease" abbrv="">rodent model</z:e> to test whether the plasminogen activator (PA) system is critical for MMP-9 activation and HI-induced brain injury in newborns </plain></SENT>
<SENT sid="3" pm="."><plain>To test this hypothesis, we examined the therapeutic effect of intracerebroventricular injection of plasminogen activator inhibitor-1 (PAI-1) in rat pups subjected to unilateral carotid <z:mp ids='MP_0006134'>artery occlusion</z:mp> and systemic <z:mp ids='MP_0005039'>hypoxia</z:mp> </plain></SENT>
<SENT sid="4" pm="."><plain>We found that the injection of PAI-1 greatly reduced the activity of both tPA and urokinase-type plasminogen activator after HI </plain></SENT>
<SENT sid="5" pm="."><plain>It also blocked HI-induced MMP-9 activation and <z:chebi fb="2" ids="33602">BBB</z:chebi> permeability at 24 h of recovery </plain></SENT>
<SENT sid="6" pm="."><plain>Furthermore, magnetic resonance imaging and histological analysis showed the PAI-1 treatment reduced <z:hpo ids='HP_0002181'>brain edema</z:hpo>, <z:mp ids='MP_0005405'>axonal degeneration</z:mp>, and cortical cell <z:hpo ids='HP_0011420'>death</z:hpo> at 24-48 h of recovery </plain></SENT>
<SENT sid="7" pm="."><plain>Finally, the PAI-1 therapy provided a dose-dependent decrease of brain tissue loss at 7 d of recovery, with the therapeutic window at 4 h after the HI insult </plain></SENT>
<SENT sid="8" pm="."><plain>Together, these results suggest that the brain PA system plays a pivotal role in neonatal cerebral HI and may be a promising therapeutic target in infants suffering hypoxic-ischemic <z:hpo ids='HP_0001298'>encephalopathy</z:hpo> </plain></SENT>
</text></document>